产品详情
Targets
Target | Value |
---|---|
SRMS | IC50: 18nM |
ACK1 | IC50: 19nM |
B-Raf(V600E) | IC50: 31nM |
C-Raf | IC50: 48nM |
MAP4K5(KHS1) | IC50: 51nM |
FGR | IC50: 63nM |
B-Raf | IC50: 100nM |
LCK | IC50: 183nM |
BRK | IC50: 213nM |
NEK11 | IC50: 317nM |
BLK | IC50: 547nM |
LynB | IC50: 599nM |
YES1 | IC50: 604nM |
WNK3 | IC50: 877nM |
MNK2 | IC50: 1.717μM |
FRK(PTK5) | IC50: 1.884μM |
CSK | IC50: 2.339μM |
Src | IC50: 2.389μM |
In vitro (25°C) | DMSO | 83 mg/mL (169.41 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 4% DMSO+30% PEG 300+5% Tween 80+ddH2O (suspension) | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.41 mL | 102.06 mL | 204.12 mL |
0.5 mM | 4.08 mL | 20.41 mL | 40.82 mL |
1 mM | 2.04 mL | 10.21 mL | 20.41 mL |
5 mM | 0.41 mL | 2.04 mL | 4.08 mL |
*The above data is based on the productmolecular weight 489.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10739 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 489.9 |
Formula | C23H18ClF2N3O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 918504-65-1 |
Synonyms | RG7204,RO5185426,Zelboraf, PLX-4032 |
SMILES | CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F |
产品资料
产品标签
Product Questions
Product Questions
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂,具有潜在的抗肿瘤活性。
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
PF-04880594
PF-04880594是RAF抑制剂,BRAF/BRAFV599E和c-RAF的IC50值分别为0.19 nM/0.13 nM和0.39 nM。
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶(MAPK)具有特异性的蛋白激酶抑制剂,具有潜在的抗肿…